These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
158 related articles for article (PubMed ID: 38291597)
1. The diagnostic performance of copeptin in clinical practice: A prospective study. Trimpou P; Bounias I; Ehn O; Hammarsten O; Ragnarsson O Clin Endocrinol (Oxf); 2024 Jul; 101(1):23-31. PubMed ID: 38291597 [TBL] [Abstract][Full Text] [Related]
2. Copeptin role in polyuria-polydipsia syndrome differential diagnosis and reference range in paediatric age. Tuli G; Tessaris D; Einaudi S; Matarazzo P; De Sanctis L Clin Endocrinol (Oxf); 2018 Jun; 88(6):873-879. PubMed ID: 29464737 [TBL] [Abstract][Full Text] [Related]
3. A COMBINED OUTPATIENT AND INPATIENT OVERNIGHT WATER DEPRIVATION TEST IS EFFECTIVE AND SAFE IN DIAGNOSING PATIENTS WITH POLYURIA-POLYDIPSIA SYNDROME. Pedrosa W; Drummond JB; Soares BS; Ribeiro-Oliveira A Endocr Pract; 2018 Nov; 24(11):963-972. PubMed ID: 30106630 [TBL] [Abstract][Full Text] [Related]
4. Diagnostic Accuracy of Copeptin in the Differential Diagnosis of the Polyuria-polydipsia Syndrome: A Prospective Multicenter Study. Timper K; Fenske W; Kühn F; Frech N; Arici B; Rutishauser J; Kopp P; Allolio B; Stettler C; Müller B; Katan M; Christ-Crain M J Clin Endocrinol Metab; 2015 Jun; 100(6):2268-74. PubMed ID: 25768671 [TBL] [Abstract][Full Text] [Related]
5. Copeptin in the differential diagnosis of the polydipsia-polyuria syndrome--revisiting the direct and indirect water deprivation tests. Fenske W; Quinkler M; Lorenz D; Zopf K; Haagen U; Papassotiriou J; Pfeiffer AF; Fassnacht M; Störk S; Allolio B J Clin Endocrinol Metab; 2011 May; 96(5):1506-15. PubMed ID: 21367924 [TBL] [Abstract][Full Text] [Related]
6. Diagnostic value of the water deprivation test in the polyuria-polydipsia syndrome. Trimpou P; Olsson DS; Ehn O; Ragnarsson O Hormones (Athens); 2017 Oct; 16(4):414-422. PubMed ID: 29518762 [TBL] [Abstract][Full Text] [Related]
7. The diagnostic role of arginine-stimulated copeptin in the differential diagnosis of polyuria-polydipsia syndrome (PPS) in pediatric age. Tuli G; Munarin J; De Sanctis L Endocrine; 2024 May; 84(2):677-682. PubMed ID: 38155322 [TBL] [Abstract][Full Text] [Related]
8. Plasma Apelin Concentrations in Patients With Polyuria-Polydipsia Syndrome. Urwyler SA; Timper K; Fenske W; de Mota N; Blanchard A; Kühn F; Frech N; Arici B; Rutishauser J; Kopp P; Stettler C; Müller B; Katan M; Llorens-Cortes C; Christ-Crain M J Clin Endocrinol Metab; 2016 May; 101(5):1917-23. PubMed ID: 26967692 [TBL] [Abstract][Full Text] [Related]
9. Copeptin as a biomarker and a diagnostic tool in the evaluation of patients with polyuria-polydipsia and hyponatremia. Christ-Crain M; Morgenthaler NG; Fenske W Best Pract Res Clin Endocrinol Metab; 2016 Mar; 30(2):235-47. PubMed ID: 27156761 [TBL] [Abstract][Full Text] [Related]
10. Rapid differential diagnosis of diabetes insipidus in a 7-month-old infant: The copeptin approach. Vergier J; Fromonot J; Alvares De Azevedo Macedo A; Godefroy A; Marquant E; Guieu R; Tsimaratos M; Reynaud R Arch Pediatr; 2018 Jan; 25(1):45-47. PubMed ID: 29241593 [TBL] [Abstract][Full Text] [Related]
11. The usefulness of copeptin for the diagnosis of nephrogenic diabetes insipidus in infancy: a case report. Bitencourt L; Fischer BL; de Oliveira Campos JL; Vaz de Castro PAS; Soares de Brito SBC; Versiani CM; Soares BS; Drummond JB; Simões E Silva AC J Pediatr Endocrinol Metab; 2021 Nov; 34(11):1475-1479. PubMed ID: 34291622 [TBL] [Abstract][Full Text] [Related]
12. A Copeptin-Based Approach in the Diagnosis of Diabetes Insipidus. Fenske W; Refardt J; Chifu I; Schnyder I; Winzeler B; Drummond J; Ribeiro-Oliveira A; Drescher T; Bilz S; Vogt DR; Malzahn U; Kroiss M; Christ E; Henzen C; Fischli S; Tönjes A; Mueller B; Schopohl J; Flitsch J; Brabant G; Fassnacht M; Christ-Crain M N Engl J Med; 2018 Aug; 379(5):428-439. PubMed ID: 30067922 [TBL] [Abstract][Full Text] [Related]
13. Diagnostic Utility of Copeptin in Pediatric Patients with Polyuria-Polydipsia Syndrome: A Systematic Review and Meta-Analysis. Ciortea DA; Petrea Cliveți CL; Bujoreanu Bezman L; Vivisenco IC; Berbece SI; Gurău G; Matei MN; Nechita A Int J Mol Sci; 2024 Oct; 25(19):. PubMed ID: 39409072 [TBL] [Abstract][Full Text] [Related]
14. The water deprivation test and a potential role for the arginine vasopressin precursor copeptin to differentiate diabetes insipidus from primary polydipsia. de Fost M; Oussaada SM; Endert E; Linthorst GE; Serlie MJ; Soeters MR; DeVries JH; Bisschop PH; Fliers E Endocr Connect; 2015 Jun; 4(2):86-91. PubMed ID: 25712898 [TBL] [Abstract][Full Text] [Related]
15. Copeptin in the differential diagnosis of hypotonic polyuria. Christ-Crain M; Fenske WK J Endocrinol Invest; 2020 Jan; 43(1):21-30. PubMed ID: 31368050 [TBL] [Abstract][Full Text] [Related]
16. Polyuria-polydipsia syndrome: a diagnostic challenge. Nigro N; Grossmann M; Chiang C; Inder WJ Intern Med J; 2018 Mar; 48(3):244-253. PubMed ID: 28967192 [TBL] [Abstract][Full Text] [Related]
17. Copeptin assays in children for the differential diagnosis of polyuria-polydipsia syndrome and reference levels in hospitalized children. Bonnet L; Marquant E; Fromonot J; Hamouda I; Berbis J; Godefroy A; Vierge M; Tsimaratos M; Reynaud R Clin Endocrinol (Oxf); 2022 Jan; 96(1):47-53. PubMed ID: 34694022 [TBL] [Abstract][Full Text] [Related]
18. Copeptin in the diagnosis of vasopressin-dependent disorders of fluid homeostasis. Christ-Crain M; Fenske W Nat Rev Endocrinol; 2016 Mar; 12(3):168-76. PubMed ID: 26794439 [TBL] [Abstract][Full Text] [Related]
19. EJE AWARD 2019: New diagnostic approaches for patients with polyuria polydipsia syndrome. Christ-Crain M Eur J Endocrinol; 2019 Jul; 181(1):R11-R21. PubMed ID: 31067508 [TBL] [Abstract][Full Text] [Related]
20. Role of copeptin in the diagnosis of traumatic neuroendocrine dysfunction. Săcărescu A; Turliuc MD; Brănișteanu DD Neuropeptides; 2021 Oct; 89():102167. PubMed ID: 34175655 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]